Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP535108.RAl_S1k0ngjNwizEba_w_bVQSxnsaAO6b5J3CEUev6Q2Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP535108.RAl_S1k0ngjNwizEba_w_bVQSxnsaAO6b5J3CEUev6Q2Q130_assertion type Assertion NP535108.RAl_S1k0ngjNwizEba_w_bVQSxnsaAO6b5J3CEUev6Q2Q130_head.
- NP535108.RAl_S1k0ngjNwizEba_w_bVQSxnsaAO6b5J3CEUev6Q2Q130_assertion description "[These results indicate that upregulation of GATA-2 may contribute to the progression to aggressive prostate cancer through modulation of expression of AR and key androgen-regulated genes, one of which, AZGP1, is associated with the progression to metastatic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP535108.RAl_S1k0ngjNwizEba_w_bVQSxnsaAO6b5J3CEUev6Q2Q130_provenance.
- NP535108.RAl_S1k0ngjNwizEba_w_bVQSxnsaAO6b5J3CEUev6Q2Q130_assertion evidence source_evidence_literature NP535108.RAl_S1k0ngjNwizEba_w_bVQSxnsaAO6b5J3CEUev6Q2Q130_provenance.
- NP535108.RAl_S1k0ngjNwizEba_w_bVQSxnsaAO6b5J3CEUev6Q2Q130_assertion SIO_000772 19684615 NP535108.RAl_S1k0ngjNwizEba_w_bVQSxnsaAO6b5J3CEUev6Q2Q130_provenance.
- NP535108.RAl_S1k0ngjNwizEba_w_bVQSxnsaAO6b5J3CEUev6Q2Q130_assertion wasDerivedFrom befree-20140225 NP535108.RAl_S1k0ngjNwizEba_w_bVQSxnsaAO6b5J3CEUev6Q2Q130_provenance.
- NP535108.RAl_S1k0ngjNwizEba_w_bVQSxnsaAO6b5J3CEUev6Q2Q130_assertion wasGeneratedBy ECO_0000203 NP535108.RAl_S1k0ngjNwizEba_w_bVQSxnsaAO6b5J3CEUev6Q2Q130_provenance.